mrna

Significant rise in mRNA technology intellectual property activity: A third quarter of innovation observed in 2024

Posted on by

SOPHIA ANTIPOLIS, France – October 09, 2024 │ Amidst the rapidly evolving landscape of medical biotechnology, especially in the therapeutic RNA sector, groundbreaking advances continue to reshape the field. The latest release of our Therapeutic mRNA patent monitor delivers comprehensive insights, underscoring a notable acceleration in intellectual property developments, pushing the boundaries of RNA-based treatments[…]

Featured image of the article Patent Race: The Competition Between BioNTech and Moderna for the mRNA Vaccine Against Monkeypox.

Patent Race: The Competition Between BioNTech and Moderna for the mRNA Vaccine Against Monkeypox

Posted on by

SOPHIA ANTIPOLIS, France – September 03, 2024 │ The last quarterly report for the 2024 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. Monkeypox virus, a new threat? Mpox, also known as monkeypox, is a viral disease caused by the[…]

Featured image of the article Q2 2024 IP Activity Reveals New Granted Patents in mRNA Delivery and a Newcomer Developing Therapeutic Circular RNA for Pet Vaccination.

Q2 2024 IP Activity Reveals New Granted Patents in mRNA Delivery and a Newcomer Developing Therapeutic Circular RNA for Pet Vaccination

Posted on by

SOPHIA ANTIPOLIS, France – September 03, 2024 │ The quarterly report for the Q2 2024 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. What’s new this quarter? Q2 2024 patenting activity maintains steady pace with notable new granted patents in[…]

Featured image of the post Replicate Bioscience unveils promising clinical progress on self-amplifying RNA at ASGCT annual meeting.

Replicate Bioscience unveils promising clinical progress on self-amplifying RNA at ASGCT annual meeting

Posted on by

SOPHIA ANTIPOLIS, France – May 13, 2024 │ KnowMade actively follows therapeutic mRNA news for its Therapeutic mRNA patent monitor service! What’s new today? REPLICATE BIOSCIENCE develops novel self-amplifying RNA (or self-replicating or srRNA) technology for use across a range of application (i.e., infectious disease, oncology, or autoimmune disease). This clinical-stage company was already identified[…]